Furosemide clearance in very preterm neonates early in life: A pilot study using scavenged samples
- 17 December 2021
- journal article
- research article
- Published by Wiley in Pediatrics International
- Vol. 64 (1) , e14735
Abstract
Background: Furosemide is an off‐label drug, frequently used as a diuretic in neonates with oliguria and/or edema. Its clearance in preterm neonates is lower than in term neonates or children. We aimed, herein, to clarify furosemide clearance (CL) in very preterm (VP) neonates (<28 weeks’ gestation) within the first 2 weeks of life and identify the factors predictive of the pharmacokinetics (PK) parameters, such as CL. Methods: Furosemide was administered at 0.5 or 1 mg/kg in a 0.5‐h infusion via a syringe pump; blood samples were drawn from an artery or vein after the intravenous injection. The serum furosemide concentration was measured using high‐performance liquid chromatography. The PK parameters were then analyzed using Bayesian estimation. Results: Thirteen blood samples were obtained from 10 VP neonates after intravenous injection. The mean postconceptional age and mean postnatal days at exposure to furosemide were 26.9 weeks and 7.1 days, respectively. The estimated mean CL was 16.5 mL/kg/h. The mean distribution volume (Vd) and elimination half‐life (t1/2) were 0.37 L/kg and 15.3 h, respectively. Furosemide CL was negatively associated with serum creatinine (SCr) [CL = 84.2 – 67.1 × SCr (mg/dL)]. Conclusions: Very preterm neonates within the first 2 weeks of life had a higher CL than subjects in other preterm neonatal studies. The SCr level was the sole parameter influencing furosemide CL and might serve as a good index for furosemide dosing in VP neonates.Keywords
This publication has 14 references indexed in Scilit:
- Drug Labeling and Exposure in NeonatesJAMA Pediatrics, 2014
- Clinical Pharmacology of Furosemide in Neonates: A ReviewPharmaceuticals, 2013
- Population Pharmacokinetics of Piperacillin Using Scavenged Samples From Preterm InfantsTherapeutic Drug Monitoring, 2012
- Blood sample volumes in child health research: review of safe limitsBulletin of the World Health Organization, 2010
- Indomethacin and renal impairment in neonatesPediatric Nephrology, 2004
- Progression of renal function in preterm neonates with gestational age ≤32 weeksPediatric Nephrology, 2000
- Development of blood–labyrinth barrier in the semicircular canal ampulla of the ratHearing Research, 1999
- Plasma and urinary kinetics of furosemide in newborn infantsThe Journal of Pediatrics, 1983
- Pharmacokinetics of furosemide in neonatesEuropean Journal of Clinical Pharmacology, 1982
- Pharmacology of furosemide in the premature newborn infantThe Journal of Pediatrics, 1980